European agency defends existing advice on later generation contraceptive pillsBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f279 (Published 14 January 2013) Cite this as: BMJ 2013;346:f279
- Sophie Arie
France has called for a Europe-wide change in how later generation oral contraceptives are prescribed, because of the risk of side effects, but the European Medicines Agency has said that so far there is no new evidence to justify additional regulations.
At a press conference on Friday France’s health minister, Marisol Touraine, said that she would ask the agency to “modify” its market authorisation for third and fourth generation contraceptive pills. She also called for clearer warnings to be provided about the risks of venous embolism associated with the newer pills.
“The objective is that these pills are no longer …
Log in using your username and password
Log in through your institution
Sign up for a free trial